Regional Analysis Of A Cohort Compassionate-Use Program And Early Access Program With Cabazitaxel Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated With Docetaxel
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY(2015)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要